Catalogo dei prodotti della ricerca

LATTANZI, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.551
EU - Europa 1.131
AS - Asia 481
SA - Sud America 41
AF - Africa 27
OC - Oceania 5
Totale 5.236
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.497
IT - Italia 455
IN - India 183
SE - Svezia 170
SG - Singapore 147
CN - Cina 127
UA - Ucraina 113
FI - Finlandia 95
AT - Austria 57
DE - Germania 56
CA - Canada 51
BG - Bulgaria 43
IE - Irlanda 43
AR - Argentina 39
GB - Regno Unito 36
FR - Francia 28
TG - Togo 14
JP - Giappone 10
RO - Romania 9
CI - Costa d'Avorio 6
CZ - Repubblica Ceca 6
BE - Belgio 5
IR - Iran 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
MX - Messico 3
NL - Olanda 3
PK - Pakistan 3
SK - Slovacchia (Repubblica Slovacca) 3
TR - Turchia 3
BR - Brasile 2
ES - Italia 2
RU - Federazione Russa 2
ZA - Sudafrica 2
AU - Australia 1
CH - Svizzera 1
DK - Danimarca 1
GR - Grecia 1
HK - Hong Kong 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
NO - Norvegia 1
PH - Filippine 1
SC - Seychelles 1
Totale 5.236
Salva come PNG Salva come JPEG
Città #
Fairfield 549
Chandler 366
Woodbridge 289
Rome 252
Ashburn 248
Seattle 197
Houston 193
Ann Arbor 178
Cambridge 174
Wilmington 165
Beijing 105
Princeton 102
Plano 83
Singapore 80
San Paolo di Civitate 76
Boston 69
Lawrence 68
Vienna 52
New York 44
San Diego 43
Sofia 43
Menlo Park 42
Federal 39
Bremen 37
Millbury 37
Jacksonville 33
Boardman 29
Dublin 28
Andover 26
Ottawa 23
Norwalk 20
Falls Church 19
Dearborn 14
Lomé 14
Helsinki 13
Paris 13
Toronto 11
Gatineau 9
Des Moines 8
Fremont 7
London 7
Phoenix 7
Abidjan 6
Milan 6
San Mateo 6
Bühl 5
Hefei 5
Indiana 5
Lappeenranta 5
Mississauga 5
Brussels 4
Kunming 4
Latina 4
Oxford 4
Auckland 3
Devinska Nova Ves 3
Fuzhou 3
Istanbul 3
Kashiwa 3
Lahore 3
Legnano 3
L’Aquila 3
Maddaloni 3
Mannheim 3
Mexico City 3
Padova 3
Redmond 3
Redwood City 3
San Francisco 3
Teramo 3
Washington 3
Barcelona 2
Bonate Sopra 2
Bridgeville 2
Brindisi 2
Dobbs Ferry 2
Genoa 2
Giussano 2
Hounslow 2
Hyderabad 2
Jesi 2
Las Vegas 2
Los Angeles 2
Monmouth Junction 2
Montréal 2
Moscow 2
Muizenberg 2
Nanjing 2
Olevano Romano 2
Pindamonhangaba 2
Prescot 2
Sacramento 2
Strasbourg 2
Tappahannock 2
Tokyo 2
Umeda 2
Viterbo 2
Aarhus 1
Aberdeen 1
Acton 1
Totale 3.977
Salva come PNG Salva come JPEG
Nome #
SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF 18,19-DEHYDROBUPRENORPHINE 118
Prokineticin system modulation as a new target to counteract the amyloid beta toxicity induced by glutamatergic alterations in an in vitro model of Alzheimer's disease 117
Sensitization of transient receptor potential vanilloid 1 by the prokineticin receptor agonist Bv8 101
N-acetyl-cysteine, a drug that enhances the endogenous activation of group-II metabotropic glutamate receptors, inhibits nociceptive transmission in humans. 94
Identification and characterization of prokineticin receptor 2 splicing variant and its modulation in an animal model of alzheimer's disease 91
Chemokines in alzheimer’s disease: new insights into prokineticins, chemokine-like proteins 91
Expression of Bv8 in pichia pastoris to identify structural features for receptor binding 90
Bv8-Prokineticins and their Receptors: Modulators of Pain 86
Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice 86
Bv8/prokineticin 2 is involved in Aβ-induced neurotoxicity 85
The prokineticin receptor antagonist PC1 rescues memory impairment induced by β amyloid administration through the modulation of prokineticin system 85
Antagonism of the prokineticin system prevents and reverses allodynia and inflammation in a mouse model of diabetes 81
PK2β ligand, a splice variant of prokineticin 2, is able to modulate and drive signaling through PKR1 receptor 79
HIV-1 Tat-induced diarrhea is improved by the PPAR alpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia 79
G-CSF related bone pain (BP) and Bv8/PK2 expression: Is there a link in breast cancer (BC) patients (pts) treated with FEC100 adjuvant chemotherapy (CT)? 78
Biological activities of Bv8 analogues 78
Controlling the activation of the Bv8/prokineticin system reduces neuroinflammation and abolishes thermal and tactile hyperalgesia in neuropathic animals. 78
Conformationally constrained opioid ligands: The Dmt-Aba and Dmt-Aia versus Dmt-Tic scaffold 74
The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain 73
Impaired nociception and inflammatory pain sensation in mice lacking the prokineticin receptor PKR1: Focus on interaction between PKR1 and the capsaicin receptor TRPV1 in pain behavior 71
Peripheral administration of prokineticin 2 potently reduces food intake and body weight in mice via the brainstem. 70
Analogues of both Leu- and Met-enkephalin containing a constrained dipeptide isostere prepared from a Baylis-Hillman adduct 69
Prokineticin 2 upregulation in the peripheral nervous system has a major role in triggering and maintaining neuropathic pain in the chronic constriction injury model 68
A palmitoylethanolamide producing lactobacillus paracasei improves clostridium difficile toxin a-induced colitis 68
Nociceptive sensitization by the secretory protein Bv8. 67
Bv8, the amphibian homologue of the mammalian prokineticins, modulates ingestive behaviour in rats 66
PC1, a non-peptide PKR1-preferring antagonist, reduces pain behavior and spinal neuronal sensitization in neuropathic mice 65
Bv8/Prokineticin proteins and their receptors 64
The prokineticin Bv8 sensitizes cutaneous terminals of female mice to heat 64
The balance of concentration between Prokineticin 2β and Prokineticin 2 modulates the food intake by STAT3 signaling 63
Antinociceptive activity of a novel buprenorphine analogue 62
Effects of the intravenous administration of [Lys7]dermorphin on local cerebral glucose utilization in the rat. 61
Pharmacology of amphibian opiate peptides 60
Prokineticins are neuroprotective in models of cerebral ischemia and ischemic tolerance in vitro 60
Pharmacological activity of a Bv8 analogue modified in position 24 60
In vitro and in vivo pharmacological activities of 14-o-phenylpropyloxymorphone, a potent mixed mu/delta/kappa-opioid receptor agonist with reduced constipation in mice 59
Age-related ultrastructural and monoamine oxidase changes in the rat optic nerve 57
Glycodermorphins: opioid peptides with potent and prolonged analgesic activity and enhanced blood-brain barrier penetration 56
Prokineticin Receptor 1 Antagonist PC-10 as a Biomarker for Imaging Inflammatory Pain 55
Novel nociceptin analogues: Synthesis and biological activity 55
The prokineticin receptor agonist Bv8 increases GABA release in the periaqueductal grey and modifies RVM cell activities and thermoceptive reflex in the rat. 55
Novel glycosylated (LyS(7))-dermorphin analogues: synthesis, biological activity and conformational investigations 54
The prokineticin receptor agonist Bv8 decreases IL-10 and IL-4 production in mice splenocytes by activating prokineticin receptor-1 54
Modulators of Pain: Bv8 and Prokineticins 53
A New Convenient Synthetic Method and Preliminary Pharmacological Characterization of Triazinediones as Prokineticin Receptor Antagonists 53
Targeting prokineticin system counteracts hypersensitivity, neuroinflammation, and tissue damage in a mouse model of bortezomib-induced peripheral neuropathy 53
Critical role for prokineticin 2 in CNS autoimmunity 52
New 2 ',6 '-dimethyl-L-tyrosine (Dmt) opioid peptidomimetics based on the Aba-Gly scaffold. Development of unique mu-opioid receptor ligands 51
Bv8/PK2 and prokineticin receptors: a druggable pronociceptive system 51
Role of Enteric Glia as Bridging Element between Gut Inflammation and Visceral Pain Consolidation during Acute Colitis in Rats 51
Identification and characterization of a new splicing variant of prokineticin 2 50
Triazine Compounds as Antagonists at Bv8-Prokineticin Receptors 49
High-fat diet impairs duodenal barrier function and elicits glia-dependent changes along the gut-brain axis that are required for anxiogenic and depressive-like behaviors 49
Opioid peptides: Synthesis and biological activity of new endomorphin analogues 48
A new opioid designed multiple ligand derived from the mu opioid agonist endomorphin-2 and the delta opioid antagonist pharmacophore Dmt-Tic 47
6-N,N-Dimethylamino-2,3-Naphthalimide a New Environment-Sensitive Fluorescent Probe in delta-Selective and mu-Selective Opioid Peptides 47
The multimodal antidepressant vortioxetine causes analgesia in a mouse model of chronic neuropathic pain 47
Involvement of the chemokine prokineticin-2 (PROK2) in Alzheimer's disease: from animal models to the human pathology 47
Synthesis and Biological Evaluation of 14-Alkoxymorphinans. 22. Influence of the 14-Alkoxy Group and the Substitution in Position 5 in 14-Alkoxymorphinian-6-ones on in Vitro and in Vivo Activities 46
Autoradiographic mapping of the opioid receptor-like 1 (ORL1) receptor in the brains of the mu-, delta-, kappa- opioid receptor knockout mice. 46
Abnormal pain sensation in mice lacking the prokineticin receptor PKR2: interaction of PKR2 with transient receptor potential TRPV1 and TRPA1 44
Production of antinociception by peripheral administration of [Lys7]dermorphin, a naturally occurring peptide with high affinity for mu-opioid receptors. 43
Bv8, a small protein from frog skin induces antidiuresis in rats 43
Serum prokineticin-2 in prepubertal and adult Klinefelter individuals 43
A Progressive Build-up of Perineuronal Nets in the Somatosensory Cortex Is Associated with the Development of Chronic Pain in Mice 43
Dermorphin and deltorphin glycosilated analogs: synthesis and antinociceptive activity after systemic administration 42
Antinociceptive effects and mechanism of opioid activity of [Lys7]dermorphin, a naturally occurring peptide with high affinity and selectivity for mu-opioid receptors 42
Highly Selective Fluorescent Analogue of the Potent delta-Opioid Receptor Antagonist Dmt-Tic 42
Identification of regions involved in the physical interaction between melanocortin receptor accessory protein 2 and prokineticin receptor 2 42
Serum substance P is increased in Parkinson's disease and correlates with motor impairment 42
Respiratory and cardiovascular effects of the mu-opioid receptor agonist [Lys 7]dermorphin in awake rat 40
Analysis of role of aromatic residues in extracellular loop 2 of Prokineticin receptor 2 in ligand binding probed with genetically encoded photo-crosslinkers 39
Bv8/Prokineticins and their Receptors A New Pronociceptive System. 38
A new buprenorphine analog with potent antinociceptive activity never induced place preference in rats. 37
Prokineticin-receptor network: mechanisms of regulation 37
HS-599: a novel long acting opioid analgesic does not induce place-prefence in rats 36
The role of prokineticin 2 in oxidative stress and in neuropathological processes 36
PHARMACOLOGY OF BV8, A NEW PEPTIDE FROM AMPHIBIAN SKIN 34
Knockdown of rat brain δ-opioid receptors by antisense oligodeoxynucleotides 34
Cardiovascular responses to the mu-opioid agonist [Lys7]dermorphin in rats 34
HALOGENATED TRIAZINEDIONES BEHAVE AS ANTAGONISTS OF PKR1: IN-VITRO ANDIN-VIVO PHARMACOLOGICAL CHARACTERIZATION 34
Differential knockdown of delta-opioid receptor subtypes in the rat brain by antisense oligodeoxynucleotides targeting mRNA. 33
HALOGENATED TRIAZINEDIONES BEHAVE AS ANTAGONISTS OF PKR1: IN-VITRO AND IN-VIVO PHARMACOLOGICAL CHARACTERIZATION 31
Effects of antisense oligodeoxynucleotides on brain delta-opioid receptor density and on SNC80-induced locomotor stimulation and colonic transit inhibition in rats. 31
Postnatal development of delta-opioid receptor subtypes in mice 30
Trypanosoma cruzi trans-sialidase induces STAT3 and ERK activation by prokineticin receptor 2 binding 30
INTERACTION BETWEEN THE MU-AGONIST DERMORPHIN AND THE DELTA-AGONIST [D-ALA(2), GLU(4)]DELTORPHIN IN SUPRASPINAL ANTINOCICEPTION AND DELTA-OPIOID RECEPTOR-BINDING 28
Reduced expression of secretogranin VGF in laryngeal squamous cell carcinoma 25
The novel peptide Bv8 regulates fluid intake in rats 25
Substance P and Prokineticin-2 are overexpressed in olfactory neurons and play differential roles in persons with persistent post-COVID-19 olfactory dysfunction 24
null 24
Olfactory neuron substance P is overexpressed in Parkinson's disease reflecting gut dysfunction 24
Versatile role of prokineticins and prokineticin receptors in neuroinflammation 23
Olfactory neuron prokineticin-2 as a potential target in Parkinson's disease 21
Opioid and Bv8 Peptides 21
Non opioid motor effects of deltorphin analogs 21
Neuropeptidi 20
Differential postnatal development of delta-opioid receptor subtypes in mouse brain 20
Glycosylated analogues of deltorphin induced antinociception after systemic administration. 19
Arginine 125 is an essential residue for the function of MRAP2 18
Totale 5.280
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.596
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.596
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.069 155 42 20 43 117 109 128 119 106 79 114 37
2020/2021475 46 82 36 34 4 32 2 29 78 79 41 12
2021/20221.079 15 62 96 21 130 47 36 101 116 88 159 208
2022/20231.353 211 262 119 132 150 130 11 104 98 18 79 39
2023/2024619 52 94 39 49 36 96 20 34 8 69 51 71
2024/202544 44 0 0 0 0 0 0 0 0 0 0 0
Totale 5.503